Related Experiment Video
Updated: Aug 12, 2026

Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
[Acute generalized cat scratch disease in myelodysplastic syndrome]
G von Kobyletzki1, R Nordmeier, M Stücker
1St. Josef Hospital, Dermatologische Klinik der Ruhr-Universität Bochum. Gregor.vonKobyletzki@ruhr-uni-bochum.de
Cat scratch disease typically causes a single skin lesion in immunocompetent individuals. However, in an immunocompromised patient with myelodysplastic syndrome, it presented with widespread vasculitic skin lesions, successfully treated with erythromycin.
Area of Science:
- Infectious Diseases
- Dermatology
- Immunology
Background:
- Cat scratch disease (CSD) is usually a mild infection caused by Bartonella henselae.
- Immunocompetent individuals typically develop a localized papule at the inoculation site.
- Myelodysplastic syndrome (MDS) can impair immune function, potentially altering CSD presentation.
Observation:
- A 73-year-old male with myelodysplastic syndrome presented with generalized petechial, papular, and vasculitic skin lesions.
- The patient had a confirmed diagnosis of cat scratch disease via lymph node biopsy.
- Diagnosis was confirmed by Warthin-Starry staining identifying the causative organism.
Findings:
- The patient's CSD manifested with atypical, widespread cutaneous vasculitis, unlike typical presentations.
- Treatment with erythromycin for three weeks led to progressive clearance of the skin lesions.
- Serological markers, including IgG antibodies against Bartonella species, showed delayed but significant increases.
Implications:
- This case highlights the potential for atypical and severe cutaneous manifestations of CSD in immunocompromised patients.
- Early diagnosis and treatment with antibiotics like erythromycin are crucial for managing severe CSD.
- Understanding altered CSD presentations in immunocompromised individuals is vital for accurate diagnosis and patient care.
More Related Videos
06:39Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
Related Concept Videos
Rocky Mountain Spotted Fever
Leishmaniasis
American Trypanosomiasis